Eli Lilly becomes first drugmaker to have a GLP-1 weight-loss pill approved in China - Reuters

More in Health

• STAT+: What to know about Biogen’s big lupus study readout

  The upcoming clinical data drop represents a high-stakes test for the pharmaceutical giant's immunology pipeline. Success or failure will directly reflect on the strategic turnaround spearheaded by Chief Executive Officer Chris Viehbacher since he took the helm in 2022. Investors and researchers are watching closely as the company attempts to validate its broader research and development overhaul.

  1 min read
• Baby buried in dog crate for 24 hours survives; South Carolina father charged

  A massive search involving over 100 first responders led authorities to the wooded area near Batesburg-Leesville after an infant disappeared from family care. Investigators noted recent domestic friction between the child's parents, though an official motive remains unconfirmed. The suspect faces multiple serious charges and has a prior criminal record from earlier this year involving assault and domestic violence.

  3 min read
• Exclusive-US FDA shelves commissioner’s voucher program for speedy drug reviews, sources say

  Food and Drug Administration has shelved its commissioner's voucher program aimed at providing speedy drug reviews, according to sources. Further details regarding the reasons for the decision or the future of the initiative were not disclosed.

  1 min read